Could Your Acne or Eczema Be Linked to Your Gut Health?
Last updated: 18 Aug 2026
Your bathroom cabinet is likely filled with topical treatments: targeted serums, barrier repair creams, spot applications, and prescription gels. You have been meticulous about your skincare routine, adjusted your products according to the season, and perhaps even experimented with strict elimination diets. Yet, despite these efforts, acne breakouts recur, and eczema flares persist. It is an understandable source of frustration when you are following established protocols, but your skin continues to react.
When surface-level interventions yield inconsistent results, it is clinically worthwhile to consider whether an internal systemic driver is at play.
The physiological link between your gastrointestinal tract and your skin is far more direct than many people realise. Beyond immediate dietary reactions, your skin health is intimately connected to what is occurring within your digestive tract—specifically, the balance of your gut microbiome and the functional integrity of your intestinal barrier. Disruption in these systems can trigger systemic inflammatory pathways that manifest directly on the skin. Reassuringly, these gastrointestinal mechanisms are both objectively testable and clinically treatable.
Find out if your Gut Health is causing Acne or Eczema
Patient-first, Holistic, Dedicated Healthcare
Understanding the Gut-Skin Connection
Your skin is your body's largest organ, and like any organ system, its condition reflects broader physiological processes occurring internally. The bidirectional communication network between the gastrointestinal tract and the integumentary system is known as the gut-skin axis [1, 2]. This two-way communication channel means that gastrointestinal disturbances can signal directly to the skin, while skin inflammation can similarly reflect systemic gastrointestinal strain.
To understand this mechanism at a cellular level, we look at the role of the intestinal microbiome. When the complex ecosystem of microorganisms in your gut becomes imbalanced—a state termed dysbiosis—the structural integrity of your intestinal lining can be compromised [3]. This increased epithelial permeability allows microbial fragments, such as lipopolysaccharides (LPS), and inflammatory metabolites to pass into the bloodstream. In response, the immune system initiates a systemic inflammatory cascade. When these pro-inflammatory signals circulate, they frequently target susceptible skin tissue, precipitating acne eruptions, aggravating atopic dermatitis (eczema), or driving rosacea flares [3].
This process is also heavily dependent on the presence of specific beneficial bacteria. Key commensal microbes ferment dietary fibres to produce short-chain fatty acids (SCFAs), most notably butyrate. Butyrate serves as the primary energy source for colonocytes and plays a critical role in maintaining tight junction proteins—such as occludin and claudin-1—that seal the intestinal barrier [4]. When dysbiosis leads to a depletion of these SCFA-producing bacteria, the gut barrier becomes hyperpermeable, allowing inflammatory mediators to enter systemic circulation and provoke skin inflammation [4].
The clinical implication is straightforward: if recalcitrant acne or persistent eczema flares occur despite rigorous topical care, the primary physiological trigger may not reside in the skin itself, but rather further upstream in the digestive tract. Because certain gastrointestinal issues can be sometimes diagnosed through clinical testing, identifying these triggers can offer a clearer path toward targeted resolution.
Possible Scientific Correlations between Gut Health and Acne/Eczema
1. H. Pylori Infection
Helicobacter pylori is a spiral-shaped bacterium that colonises the gastric mucosa. Beyond its well-established role in gastritis and peptic ulcer disease, clinical literature increasingly links H. pylori infection to extraintestinal inflammatory skin conditions, including acne vulgaris and rosacea [5, 6]. A comprehensive meta-analysis published in Gastroenterology established that approximately 50% of the global population harbours H. pylori, frequently remaining asymptomatic from a digestive standpoint [7].
From a dermatological perspective, chronic gastric infection with H. pylori can induce sustained local and systemic inflammatory cytokine release. This systemic inflammatory burden can lower the threshold for skin inflammatory conditions, worsening acne severity and triggering persistent rosacea vascular flares [5, 6]. In patients with treatment-resistant acne or rosacea, medical screening for H. pylori is a possible diagnostic step (not suitable for everyone).
However, it is always important to know that the above evidence merely shows correlation, rather than causation.
When present, eradicating the bacterial infection through a standard short course of targeted dual-antibiotic and acid-suppression therapy frequently leads to a marked reduction in skin inflammation [5]. Active infection can be diagnosed quickly through a non-invasive Urea Breath Test.
2. Dysbiosis (Gut Bacteria Imbalance)
Dysbiosis refers to a shift in microbial composition where beneficial commensal organisms are reduced, and potentially pathobiont species proliferate. This imbalance compromises the synthesis of protective short-chain fatty acids and increases the production of pro-inflammatory bacterial metabolites [3].
High-throughput sequencing studies demonstrate that individuals with moderate-to-severe atopic dermatitis frequently exhibit marked depletion of specific protective taxa, notably Akkermansia muciniphila and Faecalibacterium prausnitzii [8, 9]. These microbial species are fundamental to mucosal immune tolerance and intestinal barrier maintenance. Their absence allows low-grade intestinal inflammation to develop, which subsequently manifests as systemic and skin hyper-reactivity [8].
Stool-based gut microbiome sequencing allows your GP to evaluate your specific microbial landscape. Rather than relying on non-specific probiotic supplements, obtaining an objective baseline profile enables targeted dietary adjustments and strain-specific probiotic interventions tailored to your exact dysbiosis pattern.
3. Intestinal Permeability (Leaky Gut)
When tight junction proteins in the intestinal epithelium are disrupted by inflammation, stress, or dysbiosis, the intestinal barrier becomes excessively permeable. Under normal physiological conditions, this barrier selectively absorbs nutrients while excluding macromolecules, toxins, and bacterial fragments. When permeability increases, un-degraded dietary proteins and bacterial endotoxins enter the submucosa and bloodstream [10, 11].
This hyperpermeability is especially relevant to eczema, which is recognised medically as a systemic immune condition with skin expression, rather than an isolated skin disease. Clinical studies confirm that increased intestinal permeability correlates with greater skin severity in atopic dermatitis [10]. Addressing both mucosal barrier integrity and skin barrier function provides a far more complete therapeutic approach.
4. Food Sensitivities and Inflammation
When intestinal permeability is heightened, the immune system is exposed to partially digested food molecules that would ordinarily remain contained within the gut lumen. This exposure can induce non-IgE mediated food sensitivities, provoking recurrent inflammatory skin flares [11].
Common dietary triggers include dairy proteins, gluten, refined carbohydrates, and highly processed foods. However, individual sensitivities vary based on your underlying microbiome structure and barrier status. While temporary elimination diets can help identify triggers, eliminating foods indefinitely does not repair the underlying epithelial breach. Comprehensive gut testing helps differentiate true food intolerances from secondary sensitivities caused by intestinal hyperpermeability.
5. Stress and the Gut-Skin Cycle
The gut-skin axis is strongly modulated by the nervous system. Psychological and physiological stress triggers the activation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to elevated circulating cortisol and catecholamines. Cortisol alters gut motility, increases mucosal permeability, and reduces beneficial microbial populations, directly promoting dysbiosis [12].
Simultaneously, the emotional burden of persistent skin conditions generates additional stress, creating a biological feedback loop. Interrupting this cycle requires addressing systemic inflammation at its source. Improving gut barrier health reduces the physiological stress burden on the body, creating a more stable foundation for skin healing.
Why Skincare and Dermatology Alone Often Aren't Enough
Topical dermatological treatments and dedicated skincare routines play a crucial, evidence-based role in managing skin health. They restore epidermal lipid barriers, reduce surface bacterial colonisation (such as Cutibacterium acnes), and suppress local skin inflammation. For localized or primary skin conditions, topical management is often sufficient.
However, when acne or eczema remains persistent despite strict adherence to appropriate topical therapies, surface-level treatment alone may be addressing the downstream symptom rather than the upstream driver. Applying topical agents cannot neutralize systemic pro-inflammatory cytokines originating from an inflamed, hyperpermeable gut.
Furthermore, long-term oral antibiotic regimens (such as doxycycline or minocycline), while effective at reducing skin bacterial counts during administration, can alter the gut microbiome [13]. Broad-spectrum antibiotics reduce microbial diversity and deplete beneficial commensal populations, such as Bifidobacterium and Lactobacillus species [14]. In some patients, this antibiotic-induced dysbiosis leads to rebound acne flares or digestive symptoms upon cessation of treatment. Similarly, while topical corticosteroids are essential for acute eczema flares, they do not correct underlying systemic immune dysregulation driven by intestinal dysbiosis.
How to Tell the Difference
To determine whether gut dysfunction may be contributing to your skin condition, consider whether you notice any of the following clinical patterns:
- Dietary and Stress Triggers: Your acne breakouts or eczema flares regularly correlate with specific meals, digestive discomfort, or periods of heightened stress.
- Transient Response to Conventional Therapy: Topical treatments or oral antibiotics provide temporary improvement, but skin inflammation promptly recurs once treatment ceases.
- Concomitant Gastrointestinal Symptoms: You experience persistent digestive complaints, such as postprandial bloating, irregular bowel habits, acid reflux, abdominal discomfort, or halitosis, alongside your skin issues.
When skin symptoms co-occur with chronic digestive complaints, a detailed gastrointestinal evaluation would be prudent to consider.
When to Investigate Your Gut
It is appropriate to consider a gastrointestinal investigation if you experience:
- Persistent acne vulgaris, rosacea, or eczema that fails to respond adequately to standard topical and dermatological protocols.
- Skin flares that consistently follow digestive distress, stress, or specific dietary intake.
- Relapsing acne flares following completion of courses of systemic oral antibiotics.
- Skin inflammatory conditions accompanied by chronic bloating, altered bowel frequency, or indigestion.
- A personal or family history of atopic conditions, autoimmune disorders, or marked food intolerances.
- A history of frequent or prolonged broad-spectrum antibiotic use.
- Unexplained chronic fatigue or lethargy co-occurring with persistent skin flares.
In these clinical scenarios, investigating gastrointestinal parameters can provide useful objective data to direct your overall care plan.
Some Tests Can Help
If gut-related drivers are suspected, your doctor can recommend specific objective diagnostic assessments:
- Urea Breath Test detects active H. pylori infection. If H. pylori is present and contributing to your skin issues, treatment is straightforward.
- Gut Microbiome Test uses high-throughput genomic sequencing to assess microbial diversity, measure the abundance of key commensal species (such as F. prausnitzii and A. muciniphila), and identify specific dysbiosis patterns.
- Vitamin and Mineral Deficiency Panel. Intestinal dysbiosis and mucosal inflammation can impair nutrient absorption. Deficiencies in critical micronutrients, including zinc, vitamin D, iron, and B vitamins, directly compromise epidermal differentiation, tissue repair, and skin immune regulation [15, 16, 17]. Identifying and correcting these deficiencies supports both gut mucosal healing and skin recovery.
- For patients with multiple concerns, a comprehensive gut health screening covers the key bases in a single visit.
A structured assessment with a GP allows these targeted investigations to be conducted efficiently based on your individual medical history. The above list is not exhaustive.
*This list is non-exhausive
Beyond Your Skincare Routine
Your skin serves as an external indicator of internal physiological balance. Recalcitrant breakouts or persistent eczema flares are often signals that systemic inflammatory pathways require clinical attention.
When topical management alone has proven insufficient, looking deeper into gastrointestinal function can possibly offer an alternative approach. Identifying and correcting internal imbalances addresses the underlying drivers of inflammation, supporting lasting skin health from within.
Manage Healthy Skin and Balanced Gut
Persistent acne or eczema despite excellent skincare is a clinical signal, not a personal failing. If you've optimised your skincare routine and dermatological treatments haven't provided lasting relief, it's worth investigating your gut. A simple microbiome test or H. pylori screening at our clinic can often identify what's contributing to your skin flares.
But before you book another dermatology appointment, consider this: your skin is trying to tell you something. The answer might be deeper than any topical treatment can reach. Once you address the underlying gut issue, relief often comes faster and more completely than any skincare product ever could.
Manage Healthy Skin and Balanced Gut
Patient-first, Holistic, Dedicated Healthcare
Medical Disclaimer & Limitation of Liability
The content provided in this post is strictly for informational and educational purposes. Just as we fiercely defend our right to publish general health information, we establish an uncompromising boundary: this material is never a substitute for personalised, professional medical advice, diagnosis, or treatment.
Reading this content does not establish a doctor-patient relationship. You possess the sovereign right and responsibility to manage your own health, which means you must consult your own qualified physician before making any medical decisions based on what you read here. We explicitly disclaim all medicolegal liability for any injury, loss, or risk incurred directly or indirectly from the misinterpretation, misuse, or out-of-context application of our online content. Your health is your responsibility; seek individual professional care.
[1] Salem, I., Ramser, A., Isham, N., & Ghannoum, M. A. (2018). The gut microbiome as a major regulator of the gut-skin axis. Frontiers in Microbiology, 9, Article 1459. https://doi.org/10.3389/fmicb.2018.01459
[2] Bowe, W. P., & Logan, A. C. (2011). Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? Gut Pathogens, 3(1), Article 1. https://doi.org/10.1186/1757-4749-3-1
[3] De Pessemier, B., Grine, L., Debaere, M., Maes, A., Paetzold, B., & Callewaert, C. (2021). Gut-skin axis: Current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms, 9(2), Article 353. https://doi.org/10.3390/microorganisms9020353
[4] Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology, 10, Article 277. https://doi.org/10.3389/fimmu.2019.00277
[5] Gravina, A. G., Zagari, R. M., De Musis, C., Romano, L., Loguercio, C., & Romano, M. (2018). Helicobacter pylori and extragastric diseases: A review. World Journal of Gastroenterology, 24(29), 3204–3221. https://doi.org/10.3748/wjg.v24.i29.3204
[6] Jorgensen, A. R., Egeberg, A., Gideonsson, R., Weinstock, L. B., Thyssen, J. P., & Bazzochi, A. (2017). Rosacea and Helicobacter pylori: Links and risks. Clinical, Cosmetic and Investigational Dermatology, 10, 319–326. https://doi.org/10.2147/CCID.S124116
[7] Hooi, J. K. Y., Lai, W. Y., Ng, W. K., Suen, M. M. Y., Underwood, F. E., Tanyingoh, D., Malfertheiner, P., Graham, D. Y., Wong, V. W. S., Wu, J. C. Y., Chan, F. K. L., Sung, J. J. Y., Kaplan, G. G., & Ng, S. C. (2017). Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology, 153(2), 420–429. https://doi.org/10.1053/j.gastro.2017.04.022
[8] Song, H., Yoo, Y., Hwang, J., Na, Y. C., & Kim, H. S. (2016). Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. Journal of Allergy and Clinical Immunology, 137(3), 852–860. https://doi.org/10.1016/j.jaci.2015.08.021
[9] Lee, S. Y., Lee, E., Park, Y. M., & Hong, S. J. (2018). Microbiome in the gut-skin axis in atopic dermatitis. Allergy, Asthma & Immunology Research, 10(4), 354–362. https://doi.org/10.4168/aair.2018.10.4.354
[10] Passeron, T., Lacour, J. P., & Ortonne, J. P. (2006). Prebiotics and probiotics in atopic dermatitis. Clinical Reviews in Allergy & Immunology, 31(2-3), 205–210. https://doi.org/10.1385/CRIAI:31:2:205
[11] Mahmud, M. R., Akter, S., Tamanna, S. K., Mazumder, L., Esti, I. Z., Banerjee, S., Akter, S., Rahman, M. S., Islam, M. R., & Hossain, M. S. (2022). Impact of gut microbiome on skin health: Gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes, 14(1), Article 2096995. https://doi.org/10.1080/19490976.2022.2096995
[12] Madison, A., & Kiecolt-Glaser, J. K. (2019). Stress, diet, and the gut microbiota: Human-bacteria interactions at the core of psychoneuroimmunology and nutrition. Current Opinion in Behavioral Sciences, 28, 105–110.
https://doi.org/10.1016/j.cobeha.2019.01.011[13] Thompson, K. G., & Rainer, B. M. (2023). Profiling the effects of systemic antibiotics for acne on the gut microbiota. Dermatology Therapy, 36(4), Article e15820. https://doi.org/10.1111/dth.15820
[14] Angelakis, E., Merhej, V., & Raoult, D. (2014). Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infectious Diseases, 14(4), 347–356. https://doi.org/10.1016/S1473-3099(13)70278-2
[15] Ogawa, Y., Kinoshita, M., Shimada, S., & Kawamura, T. (2018). Zinc and skin disorders. Nutrients, 10(2), Article 199. https://doi.org/10.3390/nu10020199
[16] Umar, M., Sastry, K. S., & Al Ali, F. (2018). Vitamin D and the skin: Focus on a complex relationship: A review. Reviews in Endocrine and Metabolic Disorders, 19(1), 11–23. https://doi.org/10.1007/s11154-018-9442-9
[17] Lim, S. K., Ha, J. M., Lee, Y. H., Lee, Y. W., Choe, Y. B., & Ahn, K. J. (2016). Comparison of vitamin D levels in patients with acne vulgaris, atopic dermatitis, and healthy controls. PLoS ONE, 11(8), Article e0161108. https://doi.org/10.1371/journal.pone.0161108
